Boothbay Fund Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-479,815
Closed -$4.78M 2399
2021
Q2
$4.78M Hold
479,815
0.15% 142
2021
Q1
$4.82M Hold
479,815
0.18% 107
2020
Q4
$4.89M Buy
479,815
+29,515
+7% +$22.3K 0.18% 100
2020
Q3
$4.41M Hold
450,300
0.27% 72
2020
Q2
$4.47M Buy
+450,300
New +$305K 0.31% 67

Boothbay Fund Management's CHAQ.WS Position: Q3 2021 in Review

Boothbay Fund Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 479,815 shares — an estimated $4.78M sold.

Boothbay Fund Management first reported a position in CHAQ.WS in Q2 2020 and held it in 5 quarters. The position peaked at $4.89M in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Boothbay Fund Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 479,815 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $4.78M.
  • Boothbay Fund Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q2 2020 and held it in 5 quarters.
  • Boothbay Fund Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $4.89M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.